Chronic Disease and COVID-19: Mitigating Collateral Damage from the Pandemic

Tuesday, November 17, 2020
5:30 PM - 6:30 PM

Via Zoom Webinar.

  • Nikhil Tandon,
  • Kavita Singh,
  • Lijing Yan,
  • Daejung Kim,
  • Piya Hanvoravongchai ,
  • Jianchao Quan

This event is part of the Asia Health Policy Program (AHPP) 2020-21 Colloquium series "Health, medicine, and longevity: Exploring public and private roles"

A collaborating network of researchers summarize preliminary results from recent harmonized surveys on the impact of COVID-19 on individuals living with diabetes and hypertension, focusing on their access to medication and other care, loss of household income, (non)adherence to treatment, and worsening of symptoms. Researchers from China, India, Korea, and Thailand discuss empirical results from data gathered in the last few months. Understanding to what extent lapses in medication or other treatment have occurred, and whether telehealth or other options are associated with better outcomes, may enable locally tailored, evidence-based policy responses to help mitigate impacts on future morbidity and mortality.

Nikhil Tandon, All India Institute of Medical Sciences
Kavita Singh, Public Health Foundation of India
Lijing Yan, Duke Kunshan University
Jianchao Quan, University of Hongkong
Daejung Kim, Korea Institute for Health and Social Affairs
Piya Hanvoravongchai, Chulalongkorn University
Wasin Laohavinij, Chulalongkorn University